PreMIT

PreMIT is an Australian precision oncology and theranostics company focused on molecular imaging, radiomolecular precision oncology, and the development and clinical translation of novel radiopharmaceuticals. The company operates in conjunction with the Melbourne Theranostic Innovation Centre, where it combines clinical nuclear medicine services, advanced PET/CT imaging, genomics-informed target discovery, and translational research capabilities. PreMIT positions itself as both a clinical services and innovation platform business, supporting validation and optimized delivery of imaging and therapeutic radiopharmaceuticals. Its work spans target discovery, preclinical and clinical validation, and partnership-driven development of theranostic programs and precision oncology centers. The company appears to be private, Australia-based, and active in building research, clinical trial, and ecosystem partnerships in theranostics.